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Abstract
Focussed radiosurgery may provide a means of inducing molecular changes on the luminal
surface of diseased endothelium to allow targeted delivery of novel therapeutic compounds.
We investigated the potential of ionizing radiation to induce surface expression of intercellu-
lar adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on
endothelial cells (EC) in vitro and in vivo, to assess their suitability as vascular targets in
irradiated arteriovenous malformations (AVMs). Cultured brain microvascular EC were irra-
diated by linear accelerator at single doses of 0, 5, 15 or 25 Gy and expression of ICAM-1
and VCAM-1 measured by qRT-PCR, Western, ELISA and immunocytochemistry. In vivo,
near-infrared (NIR) fluorescence optical imaging using Xenolight 750-conjugated ICAM-1
or VCAM-1 antibodies examined luminal biodistribution over 84 days in a rat AVM model
after Gamma Knife surgery at a single 15 Gy dose. ICAM-1 and VCAM-1 were minimally
expressed on untreated EC in vitro. Doses of 15 and 25 Gy stimulated expression equally; 5
Gy was not different from the unirradiated. In vivo, normal vessels did not bind or retain the
fluorescent probes, however binding was significant in AVM vessels. No additive increases
in probe binding were found in response to radiosurgery at a dose of 15 Gy. In summary,
radiation induces adhesion molecule expression in vitro but elevated baseline levels in AVM
vessels precludes further induction in vivo. These molecules may be suitable targets in irra-
diated vessels without hemodynamic derangement, but not AVMs. These findings demon-
strate the importance of using flow-modulated, pre-clinical animal models for validating
candidate proteins for vascular targeting in irradiated AVMs.
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Introduction
Brain arteriovenous malformations (AVMs) are a leading cause of stroke in children and young
adults, accounting for 4% of hemorrhagic strokes [1]. AVMs are complex vascular abnormalities,
forming tortuous, tangled collections of vessels, characterized by abnormal connections between
arteries and veins that lack a capillary network [2]. Treatment options for brain AVMs include
surgery, embolization and highly focussed radiation (stereotactic radiosurgery). However, over
one third of patients with large and deep AVMs cannot be safely and effectively treated with cur-
rent methods. New treatments are required for these patients with life-threatening AVMs.
A biological technique that can be harnessed to produce thrombosis and occlusion inside
AVM blood vessels is highly attractive. A proposed method to achieve this goal is vascular tar-
geting. This approach has been applied in cancer therapy where unique molecular markers
expressed on the surface of tumor vessels are targeted by conjugated antibodies and pro-
thrombotic factors to induce intravascular thrombosis [3]. Molecular differences that can
discriminate diseased and normal endothelial cells (ECs) is the fundamental criterion for suc-
cessful vascular targeting. Previous studies have shown that AVM ECs are not dramatically
different to normal ECs although there are some distinctions. In vitro studies suggest a pro-
angiogenic phenotype of AVM ECs in culture [4, 5]. Hemodynamic derangements causing
turbulent flow within the tangle of AVM vessels are also postulated to modulate expression in
situ [6]. Targeting moderately expressed proteins in AVMs may not provide sufficient discrim-
ination from normal vessels, further, flow-regulated proteins may also be expressed on AVM
feeding arteries. While AVM vessels typically bypass the brain, forming arteriovenous shunts,
branches deriving from the main feeding artery can supply blood to the brain, hence their
inadvertent occlusion must be avoided.
We previously proposed that stereotactic radiosurgery could be used to prime AVM endo-
thelium, inducing focal molecular changes that could better discriminate the AVM vessels
from normal vasculature [7, 8]. We hypothesize that target molecule priming may be possible
at lower radiation doses than those currently used clinically for AVM occlusion. Lower doses
may allow treatment of large AVMs that are currently untreatable by radiosurgery, because the
high doses required to directly induce occlusion lack result in poor radiation drop-off and off-
target damage.
Previous studies have shown that radiation can induce endothelial membrane changes such
as up-regulation of various cell adhesion molecules, including intercellular adhesion molecule
1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), both in vitro and in vivo [9–16].
In addition, both these cell adhesion molecules have been well-explored as vascular targets
(reviewed in [17]) in the context of cancer [18]; the endothelial delivery of anti-thrombotic
agents [19]; and for targeting endothelial inflammation [20]. These molecules may therefore
provide potential candidates for vascular targeting of irradiated AVMs. The aims of this study
were firstly to examine the expression level of these molecules in cultured brain ECs over a
range of radiation doses (5, 15 and 25 Gy) and to determine the lowest dose able to elicit a sig-
nificant response. Secondly, we aimed to deliver this dose by Gamma Knife Surgery (GKS) to
an animal model of AVM to examine the anatomical localization, level and time course of
luminal ICAM-1 and VCAM-1 expression using in vivo optical fluorescence imaging.
Materials and methods
Animal ethics
All animal procedures were approved by the Macquarie University Animal Care and Ethics
Committee (Sydney, Australia) (Approval # 2011/011) and performed in accordance with the
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Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (8th Edi-
tion, 2013).
Cell culture and irradiation
The mouse brain endothelial cell line, bEnd.3 (ATCC) [21], was cultured in Dulbecco’s modi-
fied Eagle’s medium containing L-glutamine (2 mM), sodium pyruvate (110 mg/L), glucose
(4500 mg/L), 10% fetal bovine serum (FBS), penicillin (100 units/mL) and streptomycin (0.1
mg/mL). Cells were maintained at 37˚C in 5% CO2 and passaged at 80–90% confluence. Cells
were irradiated at 50–60% confluence in 8-well chamber slides, 6-well plates or 75 cm2 flasks
with single doses of 5, 15, or 25 Gy, with a 6MV linear accelerator (LINAC) (Elekta Synergy,
Crawley, UK) at Macquarie University Hospital (MUH) as previously described [22]. Non-
irradiated cells were used as controls.
Cell viability assay
Cell viability and death were analyzed at designated time points after irradiation using trypan
blue staining and an automated cell counter.
Real-time polymerase chain reaction (qRT—PCR)
Total RNA was extracted by RNeasy Mini-Kit (QIAGEN, Limburg, Netherlands) and reverse
transcribed using the AffinityScript QPCR cDNA Synthesis Kit (Agilent Technologies Inc.,
CA, USA). qRT-PCR was performed using a Rotor-gene 6000 system (Corbett Research, Lim-
burg, Netherlands). Reactions were performed in triplicate with a final reaction volume of
25 μL: 1.0 μL cDNA; 12.5 μL ImmoMix (Bioline, MA, USA); 0.75 μL forward and reverse
primers (GeneWorks, MA, USA); 2.5 μL SYBR Green (Life Technologies, CA, USA); 8.25 μL
nuclease-free PCR-grade water. Thermal cycling conditions consisted of denaturation at 95˚C
for 10 min, followed by 40 cycles of: 95˚C for 20 s; 58˚C for 20 s; 72˚C for 20 s; and one step at
72˚C for 7 min. Data were analyzed using the comparative Ct (threshold cycle) method and
normalized to the housekeeper hypoxanthine guanine phosphoribosyltransferase (HRPT)
[23]. Primer sequences were: ICAM-1 (forward: GCCTCCGGACTTTCGATCTT; reverse: GTCA
GGGGTGTCGAGCTTTG); VCAM-1 (forward: GGGAAGCTGGAACGAAGTATCC;reverse: TCTG
GAGCCAAACACTTGACTGT); HPRT (forward: GCTTTCCCTGGTTAAGCAGTACA; reverse:
CAAACTTGTCTGGAATTTCAAATC) [24].
Western blotting
Whole cell protein lysates were prepared using radioimmunoprecipitation (RIPA) assay buffer
(150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 0.5% deoxycholate, 0.1% SDS, 1% NP-40 substitute,
5 mM EDTA, pH 8.0, protease inhibitor cocktail (GE Healthcare, NJ, USA)). Protein extracts
(15 μg) were run on 10% polyacrylamide gels before transfer and detection with primary anti-
bodies: ICAM-1 (sc-1511R, Santa Cruz, CA, USA); VCAM-1 (ab134047, Abcam, Cambridge,
UK) and GAPDH (ab9485, Abcam) and goat anti-rabbit horseradish peroxidase (HRP)-conju-
gated secondary antibody (ab6721, Abcam). Bands were visualized using enhanced chemilumi-
nescence. GAPDH was used as a loading control. Band intensity was quantified using Image J
(http://imagej.nih.gov/ij/download.html, 1997–2014) and normalized to non-irradiated controls.
Enzyme-linked immunosorbent assay (ELISA)
Cell ELISA was carried out to determine the level of surface expression of endothelial cell
adhesion molecules after irradiation. ELISA kits for ICAM-1 (BEK-2024-1P) and VCAM-1
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(BEK-2107-1P; Biosensis, SA, Australia) were used according to the manufacturer’s instruc-
tions. To account for differences in cell confluence after radiation, the HRP signal was normal-
ized to cell number by measuring absorbance at 595 nm after Janus Green staining (Sigma-
Aldrich, MO, USA).
Immunocytochemistry
Cells were cultured in 8-well chamber slides and irradiated by LINAC at 5, 15 and 25 Gy
doses. Cells were fixed 24, 72 or 120 h after radiation with 4% paraformaldehyde prior to
blocking and incubation with anti-ICAM-1 antibody (ab119871, Abcam) or IgG2b isotype
(ab18541, Abcam) that was fluorescently tagged using Mix-n-StainTMCFTM555 antibody
labelling kit (Sigma-Aldrich), or anti-VCAM-1 antibody (ab61993, Abcam) or IgG1 isotype
(ab18407, Abcam) labelled using Mix-n-StainTMCFTM640 antibody labelling kit (Sigma-
Aldrich). Nuclei were stained using 4’,6-diamidino-2-phenylindole (DAPI) (1 μg/mL, Life
Technologies). Images were captured with fixed parameters using a confocal microscope (SP5,
Leica Microsystems, Wetzlar, Germany) and analyzed with ImageJ.
Rat AVM model and Gamma Knife surgery
An arteriovenous fistula (AVF) was created surgically in isoflurane-anesthetized 6-week old,
male Sprague-Dawley rats (n = 48) by anastomosing the caudal end of the left external jugular
vein to the left common carotid artery as described in detail previously [25, 26]. The AVF was
considered ready for Gamma Knife surgery (GKS) six weeks following creation. Anesthetized
rats (n = 24) were treated using a single-fraction stereotactic radiosurgical dose administered
using a Leksell Gamma Knife Perfexion (Elekta Instruments, Stockholm, Sweden) at Mac-
quarie University Hospital (Sydney, Australia). GKS planning by axial full-body CT scanning
with 3D reconstruction and subsequent treatment was performed as described [25], with the
exception that a single marginal 15 Gy dose of radiation was delivered.
Near-infrared (NIR) dye preparation and NIR fluorescence optical in vivo
imaging
In vivo fluorescence optical imaging was performed to localize and quantify luminal expression
of ICAM-1 and VCAM-1 in the AVM model. The antibody-dye probe was prepared by conju-
gating the NIR dye, Xenolight CF750 (Caliper Life Sciences Inc., MA, USA, PK1125674), to
antibodies targeting ICAM-1 (#554967, BD Biosciences, CA, USA) or VCAM-1 (#559165, BD
Biosciences), or an IgG1 isotype control antibody (#553447, BD Biosciences), and the degree
of labelling routinely established at 2–2.2 dye molecules per protein according to the manufac-
turer’s instructions (Caliper Life Sciences, Inc.). For imaging, each anesthetized rat was placed
prone in a Kodak In Vivo Multispectral Imaging System FX cabinet (Carestream, NY, USA).
The Xenolight 750-conjugated probes were injected via the tail vein, followed by a NIR fluores-
cence image (excitation filter, 730 nm; emission filter, 790 nm; exposure time, 60 s; bin = 2 × 2;
f-stop = 2.80; field of view = 120 mm). An X-ray image (exposure time, 60 s; f-stop = 2.5; field
of view = 120 mm) was taken immediately after to allow anatomical localization of the fluores-
cence signal. Prior to probe injection, an image in the Xenolight 750 NIR fluorescence channel
was taken to obtain a background reading.
Dosing was optimized according to signal intensity and dye clearance from the body. The
optimal time for imaging for both Xenolight 750 probes was 12 h post-injection, using a 25 μg/
kg concentration of dye conjugate (not shown). A Xenolight 750-conjugated IgG1 mouse iso-
type control antibody (25 μg/kg) was used as a negative control to account for non-specific
binding (n = 6). A total of 28 animals with AVM creation were distributed for Xenolight
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750-ICAM-1 or Xenolight 750-VCAM-1 probe testing after sham or GKS. On days 1, 7, 21, 42,
63 and 84 post-irradiation or sham, animals were injected via the tail vein as described. The
same animals were recovered after imaging and used across all time points.
Analysis of in vivo fluorescence imaging
Image analysis was performed with ImageJ. Original images were exported as 16-bit files,
opened in sequence, converted to stack and the rolling ball algorithm used to subtract back-
ground. The images were artificially coloured as “Fire” and stacked images converted to mon-
tage with a scale showing high (yellow) and low (purple) fluorescent signal intensity. A region
of interest (ROI) was depicted around the AVM area (the “target” area) and an ROI of equal
size was depicted on the lateral sides of each rat in the axillary region (“non-target” area). The
ROI in pre-injection images was used for background calculation. Mean fluorescence intensity
(MFI) for each image was calculated as follows: (target ROI–background ROI)/(non-target
ROI–background ROI). Optimization experiments express the data as MFI and are given in
arbitrary units. To account for inter-subject variation, MFI data were normalized to matched
animal data at day 1 to reduce inter-animal variation in the time course analysis.
Ex vivo fluorescence imaging
Immediately after in vivo imaging at day 84, rats were perfused with saline and selected tissues
excised. Ex vivo NIR fluorescence imaging was performed under the same parameters using
the In Vivo Multispectral Imaging System. Selected AVM tissues were the left common carotid
artery (CCA), the AVM nidus and the left external jugular vein (EJV); the right CCA and right
EJV (contralateral vessels) were used as control tissues.
Statistical analysis
All data are presented as mean ± standard error of the mean (SEM). Data were plotted and
analyzed using Prism v 6.0 (GraphPad). For in vivo imaging, Kruskal-Wallis with Dunn’s post-
hoc analysis was performed for non-parametric data. Parametric data were analyzed by
repeated measures two-way analysis of variance (ANOVA) to consider the effects of treatment
and time. For immunocytochemistry, ELISA and qPCR-RT, data were analyzed by two-way
ANOVA with Bonferroni corrections. Western data were analyzed by one-way ANOVA with
Bonferroni corrections. P values less than or equal to 0.05 were considered significant.
P<0.05, P<0.01, P<0.001, P<0.0001.
Results
Effect of irradiation on cell viability
Cell viability was determined at 6, 24, 48 and 72 h after irradiation by automated trypan blue
assay. In non-irradiated cells, the number of live cells continued to increase over 72 h (Fig 1A
and 1B). In contrast, radiation doses of 15 Gy and 25 Gy significantly reduced the number of
viable cells and induced substantial morphological changes in cells remaining adherent after
48 h. Morphological changes were consistent with the development of stress-induced senes-
cence, characterized by cellular hypertrophy and enlarged, often multinucleated or multilobed,
nuclei, consistent with previous studies [27, 28].
Radiation increases ICAM-1 and VCAM-1 gene and protein expression
Relative gene expression levels of ICAM-1 increased in a linear fashion with time and dose
(Fig 2A). There was a significant difference observed between cells irradiated with 5 Gy and
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cells irradiated with 15 Gy and 25 Gy, but no significant difference between doses of 15 or 25
Gy at any time-point. At the protein level, western blotting demonstrated that ICAM-1
increased linearly with time at a maximum dose of 25 Gy (Fig 2B). At the time of peak expres-
sion (120 h), there was a dose-dependent increase in ICAM-1 expression with a significant
Fig 1. Effect of radiation on bEnd.3 cell morphology and viability. (A) Representative images of bEnd.3
cells after radiation at doses of 15 and 25 Gy. Scale bar = 20 μm. All images at 200×magnification. (B) Cell
viability was determined by trypan blue assay. Values are mean ± SEM, n = 3 for each group.
https://doi.org/10.1371/journal.pone.0185393.g001
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difference in expression relative to non-irradiated cells at 15 Gy and 25 Gy (Fig 2C and 2D).
There was no significant difference between non-irradiated cells and cells exposed to 5 Gy, nor
between doses of 15 Gy and 25 Gy, reflective of the gene expression data.
For VCAM-1 gene expression, doses of 15 Gy and 25 Gy significantly increased gene
expression relative to non-irradiated cells, peaking at 96 h (Fig 2E). There was no significant
induction at a dose of 5 Gy. Expression was marginally higher at 15 Gy relative to 25 Gy but
not statistically significant. At the protein level, western blotting analysis demonstrated that
VCAM-1 peaked 72 h after irradiation at the maximal dose of 25 Gy (Fig 2F). At the 72 h peak,
there was a significant difference between non-irradiated and 15 Gy and 25 Gy treatment
Fig 2. Quantitative real-time PCR and western analysis of ICAM-1 and VCAM-1 expression in irradiated
bEnd.3 cells. qRT-PCR analysis of ICAM-1 (A) and VCAM-1 (E) gene expression, n = 4 independent experiments.
Representative western blots (time course) of ICAM-1 (B) and VCAM-1 (F) protein at 25 Gy. Representative western
blots (dose response) of ICAM-1 expression (120 h) (C) and VCAM-1 expression (72 h) (G) post-irradiation. ICAM-1
(D) and VCAM-1 (H) protein expression quantitated using Image J, n = 4. Values are mean ± SEM. Data were
normalized to GAPDH (westerns) or HPRT (qRT-PCR).
https://doi.org/10.1371/journal.pone.0185393.g002
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groups (Fig 2G and 2H). As noted for gene expression, VCAM-1 protein levels appeared
higher in response to 15 Gy compared to 25 Gy, however this did not reach statistical
significance.
Radiation increases cell surface expression of ICAM-1 and VCAM-1
To ensure the gene and protein expression data for ICAM-1 and VCAM-1 after irradiation
correlated with surface translocation, an important factor for in vivo vascular targeting, whole-
cell ELISA assays and immunocytochemistry were used to examine surface expression. Consis-
tent with the qRT-PCR and western blot results, there was a marked increase in cell surface
expression of ICAM-1 in adherent bEnd.3 cells post-irradiation as detected by ICAM-1-spe-
cific ELISA (Fig 3A). Expression increased dramatically in irradiated cells at doses of 15 Gy
and 25 Gy however there was no significant difference at a dose of 5 Gy relative to non-irradi-
ated cells. A dose of 15 Gy showed higher surface expression of ICAM-1 compared to 25 Gy.
Immunocytochemical analysis showed that ICAM-1 was low at early time-points and in the
absence of radiation treatment but increased over time and with radiation dose (Fig 3B and
3C), in association with the senescence-like morphological enlargement of the remaining
adherent cells [27, 28]. Cells irradiated with 15 and 25 Gy showed a significant elevation com-
pared to non-irradiated cells. There was no significant difference between a dose of 5 Gy and
non-irradiated control cells.
ELISA quantitation of VCAM-1 cell surface expression demonstrated that VCAM-1 was
significantly elevated in response to irradiation with 15 Gy and 25 Gy doses (Fig 3D). No sig-
nificant increase was evident in cells dosed at 5 Gy, nor was there a significant difference
between 15 Gy and 25 Gy. Immunocytochemical analysis showed that VCAM-1 was poorly
expressed at early time-points and in the absence of radiation but increased with dose and
time (Fig 3E and 3F). Cells irradiated at 5 Gy showed no significant difference to non-irradi-
ated cells. At the 120 h time-point, VCAM-1 expression was higher in response to 15 Gy than
25 Gy, consistent with trends in gene and protein analysis. Elevated VCAM-1 expression was
also associated with morphological changes, including flattening and hypertrophy, characteris-
tic of radiation-induced cellular senescence [27, 28].
Xenolight 750-ICAM-1 and VCAM-1 probes bind specifically within AVM
vessels
Preliminary in vivo imaging experiments optimized intensity and clearance with administra-
tion of Xenolight 750-ICAM-1 or VCAM-1 probes at a concentration of 25 μg/kg, with images
taken 12 h post-injection (not shown). Non-specific binding was examined using the non-tar-
geting Xenolight 750-isotype control injected at day 21 post-irradiation or sham (n = 6, each
cohort; 25 μg/kg). No fluorescent signal was detected in response to this non-targeting probe
in any animal either sham-irradiated or irradiated (representative image of irradiated animal
shown in Fig 4A). In contrast, the Xenolight 750-ICAM-1 probe produced a fluorescent signal
localized specifically to the AVM area both in non-irradiated (Fig 4B top panel) and irradiated
animals (Fig 4B lower panel) injected at day 21 post-irradiation. Similarly, for the Xenolight
750-VCAM-1 probe injected in non-irradiated (Fig 4C top panel) and irradiated (Fig 4C lower
panel) rats at day 21 post-irradiation, fluorescent conjugate accumulated only within the AVM
area as found for ICAM-1. Quantification of in vivo fluorescence showed a significant 4-fold
difference between non-targeting and Xenolight 750-ICAM-1 probes (Fig 4D) and a 13-fold
increase between non-targeting and Xenolight 750-VCAM-1 probes (Fig 4E) for both non-
irradiated and irradiated rats at day 21 (P<0.05). There was no significant difference between
non-irradiated and irradiated animals for either molecule at this time point.
Imaging of adhesion molecules in irradiated AVMs
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Expression of ICAM-1 and VCAM-1 is not further modulated by
irradiation in the rat AVM
In vivo imaging was performed over a period of 84 days to study the temporal expression of
cell surface ICAM-1 and VCAM-1 post-irradiation with the Xenolight 750 probes. For ICAM-
1, basal expression in the non-irradiated AVMs remained high across all time points. Raw data
were normalized to MFI values day 1 post-irradiation given there was no significant difference
in mean MFI between irradiated and control groups at this time point (mean MFI 4.8 ± 1.2 in
sham vs 4.5 ± 0.9 in irradiated animals). When the data were normalized to reduce inter-ani-
mal variability and examine expression over time, there was no significant change over the 84
days in sham animals (Fig 5A). After irradiation, a 1.6-fold increase was evident by day 7
which remained stable to day 84, however there was no statistical difference at any time point.
Repeated measures analysis did not reveal any significant effect of time or treatment on
ICAM-1 expression. Ex vivo imaging of excised vessels after probe injection at day 84 showed
elevation of Xenolight 750-ICAM-1 binding in the AVM vessels (nidus, CCA and EJV) relative
to their respective contralateral controls with statistical significance at the EJV (Fig 5C). There
was no significant difference between non-irradiated and irradiated vessels at each site.
For VCAM-1, basal expression in non-irradiated animals was high relative to normal ves-
sels in the AVM region across all time points. Raw data were normalized to MFI values day 1
post-irradiation given there was no significant difference in mean MFI between irradiated and
control groups at this time point (mean MFI 5.9 ± 1.0 in sham vs 7.9 ± 3.2 in irradiated ani-
mals). In both sham and irradiated animals, normalized mean MFI increased up to day 21
then slowly decreased over the 84 day period (Fig 5B). There was no significant difference
between non-irradiated and irradiated animals at any time point, similar to ICAM-1. Repeated
measures analysis did not reveal any significant effect of time or treatment on VCAM-1
expression. Ex vivo imaging confirmed elevated Xenolight 750-VCAM-1 binding in AVM ves-
sels relative to the respective contralateral vessels, with no significant difference between irra-
diated and non-irradiated vessels (Fig 5D).
Discussion
In this study, we examined the potential utility of using cell adhesion molecules ICAM-1 and
VCAM-1 as vascular targets in AVMs after radiation priming. In vitro we found that radiation
doses of 15–25 Gy induce surface expression of ICAM-1 and VCAM-1 in brain microvascular
endothelial cells where basal expression is nominal, and that this expression is driven primarily
at the level of transcription. Using in vivo NIR-fluorescence optical imaging, we found that
normal vessels have low endogenous ICAM-1 and VCAM-1 expression, precluding binding of
our targeted probes, but revealed that AVMs express high basal levels of these molecules,
which was not further enhanced by a single focussed dose of radiation at 15 Gy.
Radiation is well known to induce ICAM-1 and VCAM-1 expression in various cultured
cells, including ECs, as also shown in this study. Doses ranging from 2 to 20 Gy have been
Fig 3. ELISA and immunocytochemical analysis of ICAM-1 and VCAM-1 expression in irradiated bEnd.3
cells. ELISA analysis of surface ICAM-1 (A) and VCAM-1 (D) expression in irradiated bEnd.3 cells normalized to
Janus green absorbance to account for changes in cell number. Immunocytochemistry was performed on bEnd.3
cells using CF555-conjugated ICAM-1 or CF640-conjugated VCAM-1 antibodies (red). Staining was quantitated as
integrated density using Image J (arbitrary units) for ICAM-1 (B) and VCAM-1 (E). Representative images are
shown at 120 h (ICAM-1) (C) or 72 h (VCAM-1) (F) post-radiation at doses of 0–25 Gy. Isotype controls for ICAM-1
(IgG1-CF555) and VCAM-1 (IgG2b-CF640) showed no staining (representative images shown at 25 Gy, 72h).
Cells were counterstained with DAPI to visualize nuclei (blue). All images were acquired at a magnification of 200×
(scale bar = 100 μm). Values are mean ± SEM, n = 3 for each group.
https://doi.org/10.1371/journal.pone.0185393.g003
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shown to induce ICAM-1 expression in human umbilical vein ECs (HUVEC) [9, 11, 12];
ICAM-1 expression in human bone marrow ECs [10]; ICAM-1 and VCAM-1 expression in
human dermal microvascular ECs (HDMEC) [12, 13]; and VCAM-1 on primary cultures of
Fig 4. In vivo near-infrared fluorescence imaging of Xenolight 750 probes in the rat AVM model. Rats
with an AVM creation were sham treated or irradiated with a 15 Gy marginal dose to the AVM region by
Gamma Knife and imaging performed 12 h after conjugate dye injection (25 μg/kg). Representative montages
of x-ray (left), fluorescent (centre) and merged (right) images after injection of Xenolight 750 probes: (A)
Xenolight-750 isotype control in irradiated animal; (B) Xenolight 750-ICAM-1 probe and; (C) Xenolight
750-VCAM-1 probe, at day 21 after sham (top panels) or radiation (bottom panels). Image J quantitation of
fluorescence at day 21 post-irradiation or sham with Xenolight 750-ICAM-1 (D) or Xenolight 750-VCAM-1 (E)
probes and Xenolight-750 isotype control probe.
https://doi.org/10.1371/journal.pone.0185393.g004
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murine pulmonary endothelial cells [14]. The only previous study performed in a brain endo-
thelial cell line demonstrated a transient ICAM-1 and VCAM-1 up-regulation at a dose of 50
Gy [29]. Our current results show effective doses (15–25 Gy) in brain microvascular EC that
fall well within these ranges, but together show that effective dose in vitro can vary consider-
ably depending on endothelial cell type, the use of primary versus immortalized cell lines, and
on culture conditions.
In vitro, doses of 15 and 25 Gy were equally effective at inducing ICAM-1 and VCAM-1
expression in this study. Given cell viability was higher at 15 Gy relative to 25 Gy, a dose of 15
Gy was chosen for translation to our pre-clinical AVM model, on the assumption that this
dose would induce vascular targets while minimizing damage to surrounding cells. Our aim is
to identify targetable molecular changes that occur at lower doses than those used currently
for clinical induction of AVM occlusion. Single-fraction stereotactic radiosurgery dose regi-
mens demonstrate that for small AVMs, doses within the range of 15–25 Gy are effective with
obliteration rates of 72–96% [30–32]. Occlusion rates improve with increasing dose, however a
marginal dose less than 15 Gy rarely obliterates AVMs [30]. For larger AVMs, hypofractio-
nated stereotactic radiosurgery dispensing doses in the range of 7 Gy per fraction (4–5 frac-
tions) can achieve occlusion but with higher rates of complication [30, 33]. Applying a lower
Fig 5. Time course of ICAM-1 and VCAM-1 expression in the rat AVM model. Xenolight-750 probe binding was
examined over a period of 84 days for ICAM-1 (A) and VCAM-1 (B) in control and irradiated (15 Gy) animals (n = 7 per
group). Raw MFI (mean fluorescence intensity) was normalized to day 1 in matched animals to reduce inter-animal
variation. No significant differences were detected at any time between irradiated and control AVMs. Ex vivo image
analysis of Xenolight 750-ICAM-1 (C) and Xenolight 750-VCAM-1 (D) probe binding in excised tissue: common carotid
artery (CCA), external jugular vein (EJV) (n = 7).
https://doi.org/10.1371/journal.pone.0185393.g005
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radiation dose has many clinical advantages. Reducing the dose will increase the size of AVM
lesions that can be treated, providing treatment options for patients with large AVMs currently
classed as untreatable. Lower doses reduce the likelihood of radiation damage to normal cells
surrounding the AVM tissue. Use of irradiation as a vascular primer in non-AVM contexts
would also benefit from a minimal dose of radiation for this same reason.
The absence of effect of radiation on ICAM-1 and VCAM-1 expression in vivo may be a
result of the non-irradiated AVM vessels already expressing a high level of ICAM-1 and
VCAM-1 on their endothelial surface. We previously reported on the presence of basal endo-
thelial VCAM-1 expression in this model using immunohistochemical studies [34], where we
observed an increase in response to a 25 Gy dose of radiation at day 21. Potentially, the use of
15 Gy rather than 25 Gy in this study reduced the significance of the effect in vivo, even though
this dose significantly increased expression of ICAM-1 and VCAM-1 in vitro. Although radia-
tion may not induce additional expression of ICAM-1 and VCAM-1 over the high basal levels
within the context of AVM treatment, the lack of binding in the normal vasculature together
with findings from other in vivo studies that show significant endothelial induction in non-
AVM contexts [14–16] suggests these molecules may be targetable in other pathological con-
texts, where hemodynamic changes are not inherent.
The presence of high basal ICAM-1 and VCAM-1 and lack of further induction with radio-
surgery is an important finding and highlights the importance of validating potential candi-
dates within a suitable pre-clinical model. The created AVM animal model has similarities in
hemodynamic, histological, molecular and ultrastructural characteristics to human AVMs [25,
26]. The AVM model consists of a large arterial input, and a nidus with branching vessels that
all drain into a single draining vein. Where in vitro studies cannot replicate the altered flow
conditions and other complexities of the human AVM, the rat AVM model can replicate
many of these factors. Previous studies in this AVM model have shown that creation of the rat
AVM causes significant hemodynamic changes almost immediately and maintenance of a
high flow state [26]. Hemodynamic derangements may be responsible for the increased adhe-
sion molecule expression. In vitro studies have revealed that oscillatory shear stress stimulates
endothelial ICAM-1 and VCAM-1 expression [6], while laminar shear stress stimulates
ICAM-1 but not VCAM-1 expression [35]. The flow-mediated increase in inflammatory mole-
cule expression at the surface of AVM vessels may form part of the propensity of human AVM
vessels to rupture or form aneurysms. In the AVM model, we hypothesize that the hemody-
namic derangements stimulate significant molecular signalling leading to expression of both
ICAM-1 and VCAM-1, precluding further induction in response to the radiation dose deliv-
ered in this study.
Given the flow-modulated ICAM-1 and VCAM-1 expression found in the rat AVM model,
a question remains as to whether this level of expression occurs in hemodynamically deranged
human AVMs. We previously demonstrated faint to moderate expression of ICAM-1 and
VCAM-1 in human AVMs using immunohistochemistry [36]. Elevated expression of ICAM-1
and VCAM-1 in AVM tissue could be a result of increased levels of shear stress [35], or high
levels of vascular endothelial growth factor or cytokines [37]. The expression of these adhesion
molecules in human AVMs is consistent with the elevated basal expression in the rat AVM
and further validates the model. It is difficult to determine, however, if the level expressed in
human AVMs would be sufficient to discriminate them from normal vessels, as appeared to be
the case for the rat AVMs, even in the absence of radiation. Further, we cannot preclude that
this expression does not occur in feeding arteries of AVM vessels, which are also subject to
high flow. While AVM vessels typically form an arteriovenous shunt, bypassing the brain,
feeding arteries may direct branches into the normal brain, and occlusion of these vessels
would be detrimental to brain blood supply. Taking this under consideration, to ensure
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targeting with high specificity, the main criterion in the context of this study must be to iden-
tify those candidates that have a significantly higher level of expression after irradiation than
the basal level found on AVM vessels. An ideal candidate protein would lack or have very low
basal expression in either the human or rat AVM prior to radiation. Thus we conclude that
ICAM-1 and VCAM-1 may not be ideal targets in the context of adjuvant treatments for radia-
tion-primed AVMs.
Conclusions
In conclusion, this study found that ICAM-1 and VCAM-1 are poorly expressed on unstimu-
lated endothelial cells in vitro but can be up-regulated and expressed at high levels on the cell
surface in response to radiation treatment. While these molecules may provide legitimate radi-
ation-primed targets in other vascular contexts where basal levels are low, the significantly ele-
vated expression in rat AVMs, delineated in this study using in vivo optical imaging, and their
potential presence in the feeding arteries of human AVMs, suggests they may be less than ideal
in this setting. These findings highlight that the use of appropriate animal models that ade-
quately model the hemodynamic derangements of human AVMs are highly important to vali-
dating candidate proteins that can adequately discriminate not only AVM vessels from normal
vessels, but AVM vessels from feeder vessels or irradiated tissues.
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